HROWHarrow Health, Inc.

$1B

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$89M+22.2% YoY

Gross Profit

$63M71.3% margin

Operating Income

$2M2.2% margin

Net Income

-$14M-15.9% margin

EPS (Diluted)

$-0.51

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$6M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$157M

Total Liabilities

$130M

Stockholders' Equity

$28M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89M	$72M	+22.2%
Gross Profit	$63M	$54M	+16.5%
Operating Income	$2M	$2M	+18.9%
Net Income	-$14M	-$18M	+21.8%

HROW FY 2022 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena